Akari Therapeutics PLC
F:CLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Akari Therapeutics PLC
F:CLA
|
US |
|
Compagnie de Saint Gobain SA
F:GOBU
|
FR |
|
O
|
Oddity Tech Ltd
NASDAQ:ODD
|
IL |
|
Continental AG
F:CONA
|
DE |
|
AXA SA
MIL:1CS
|
FR |
|
E
|
Exelon Corp
LSE:0IJN
|
US |
|
C
|
Capital One Financial Corp
F:CFX
|
US |
|
American International Group Inc
F:AINN
|
US |
|
G
|
Greencoat Renewables PLC
F:GRP
|
IE |
|
Compagnie Generale des Etablissements Michelin SCA
F:MCHA
|
FR |
|
A
|
Abercrombie & Fitch Co
XMUN:AFT
|
US |
|
N
|
Nikon Corp
XMUN:NKN
|
JP |
|
M
|
Marathon Petroleum Corp
XMUN:MPN
|
US |
|
S
|
Standard Chartered PLC
OTC:SCBFY
|
UK |
|
B
|
Boeing Co
SWB:BCO
|
US |
|
A
|
Ambev SA
BMV:ABEVN
|
BR |
|
Subsea 7 SA
F:SOCA
|
UK |
|
Japan Tobacco Inc
OTC:JAPAF
|
JP |
|
G
|
GoGold Resources Inc
F:GGD
|
CA |
|
Roche Holding AG
SIX:ROG
|
CH |
|
L
|
Laboratory Corporation of America Holdings
DUS:LAB
|
US |
Bankruptcy Probability
Akari Therapeutics PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Akari Therapeutics PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Akari Therapeutics PLC
NASDAQ:AKTX
|
7.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
894.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
532.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
207B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
275.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
216.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Akari Therapeutics PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Akari Therapeutics PLC has total debt of 754k USD. This includes both short-term (754k USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
